早期胃癌非治愈性内镜切除后追加手术与不手术治疗的更新Meta分析
本Meta分析纳入26项英文研究共9177例早期胃癌非治愈性内镜切除后患者,比较追加手术(4903例)与不手术(4274例)的预后。追加手术组5年OS、8年OS、5年DSS、DFS、RFS、CSS均显著更优,亚组分析显示70岁以上患者亦获益更多。
要点
- 非治愈性内镜切除后追加手术可显著改善5年总生存(OR=3.37)。
- 追加手术组5年无复发生存优势显著(OR=9.14)。
- 70岁以上患者追加手术亦获益(OR=3.09)。
核心结论
- 早期胃癌非治愈性内镜切除后追加手术组的预后指标显著优于不手术组。
研究设计与样本
- 检索PubMed、Embase和Web of Science数据库,纳入截至2024年5月发表的26项英文研究,共9177例早期胃癌非治愈性内镜切除后患者。
主要发现
- 追加手术组5年OS的OR=3.37(95%CI 2.91-3.91,p<0.00001),HR=0.51(95%CI 0.41-0.64,p<0.00001)。
- 追加手术组8年OS的OR=1.96(95%CI 1.22-3.16,p=0.005)。
- 追加手术组5年DSS的OR=3.08(95%CI 2.08-4.55,p<0.00001)。
- 追加手术组5年DFS的OR=4.17(95%CI 1.53-11.4,p=0.005)、5年RFS的OR=9.14(95%CI 3.63-23.01,p<0.00001)、5年CSS的OR=2.54(95%CI 1.32-4.9,p=0.005)。
- 亚组分析显示70岁以上患者从手术获益更多(OR=3.09,95%CI 2.37-4.02,p<0.00001)。
临床怎么用
- 对于早期胃癌非治愈性内镜切除后患者,追加手术可显著改善长期生存预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Debate regarding whether additional surgery should be the preferred treatment option for patients with early gastric cancer who have undergone noncurative endoscopic resection is ongoing. OBJECTIVES: This meta-analysis aims to provide clarity for clinicians and patients to facilitate better informed treatment decisions. METHODS: Our meta-analysis involved searches of PubMed, Embase, and Web of Science databases. We analyzed the following prognosis-related indicators in groups receiving additional surgical or nonsurgical treatment: 5-year overall survival (OS), 8-year overall survival (OS), 5-year disease-specific survival (DSS), 5-year disease-free survival (DFS), 5-year recurrence-free survival (RFS), 5-year cancer-specific survival (CSS), and clinicopathological data. RESULTS: After applying strict inclusion and exclusion criteria, 26 studies published in English through May 2024 were included, comprising data from 9177 patients with early-stage gastric tumors following noncurative endoscopic resection. These patients were categorized into additional surgery (n = 4903) and nonsurgical (n = 4274) groups. The following outcomes were significantly better in the additional surgery group: 5-year OS (odds ratio [OR] = 3.37, 95% confidence interval [CI] = 2.91-3.91, p < 0.00001; hazard ratio [HR] = 0.51, 95% CI = 0.41-0.64, p < 0.00001), 8-year OS (OR = 1.96, 95% CI = 1.22-3.16, p = 0.005), 5-year DSS (OR = 3.08, 95% CI = 2.08-4.55, p < 0.00001), 5-year DFS (OR = 4.17, 95% CI = 1.53-11.4, p = 0.005), 5-year RFS (OR = 9.14, 95% CI = 3.63-23.01, p < 0.00001), and 5-year CSS (OR = 2.54, 95% CI = 1.32-4.9, p = 0.005). Additionally, subgroup analysis revealed that patients over 70 years old benefitted more from surgery (OR = 3.09, 95% CI = 2.37-4.02, p < 0.00001). The results of the analysis were significant, with minimal heterogeneity. CONCLUSIONS: Our review revealed that the prognostic indicators of patients in the additional surgery group were greater and cannot be ignored.
引用
- Wang B, Zhu J, Gao N, et al. Updated evaluation of additional surgery versus non-gastrectomy treatment for early gastric cancer after noncurative endoscopic resection: a meta-analysis. Surg Endosc. 2026. PMID: 41644645. doi:10.1007/s00464-026-12606-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。